<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02928328</url>
  </required_header>
  <id_info>
    <org_study_id>N-20160037</org_study_id>
    <nct_id>NCT02928328</nct_id>
  </id_info>
  <brief_title>Assessment of Peripheral GABA Receptors for Local Pain Relief</brief_title>
  <official_title>Vurdering af Perifere GABAA-receptorer Med Henblik på Lokal Smertelindring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of peripheral GABAA receptor activation on pain and sensitivity in healthy human
      subjects has never been investigated. However, as earlier studies suggest that activation of
      peripheral GABAA receptors is anti-nociceptive in rats, it is important to determine if these
      findings can be translated into human subjects to determine if peripheral GABAA receptors are
      a viable target for future analgesic drug development.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subproject I This study will test if oral administration of GABA containing solutions will
      reduce the pain and sensitivity induced by application of capsaicin to the tongue of healthy
      human subjects. Thirty, pain-free men (n=15) and women (n=15) for the oral cavity study.

      Subproject II This study will test the hypothesis that intramuscular injection of GABA alone
      will not be painful, but will reduce muscle pain sensitivity in healthy human subjects.
      Thirty, pain-free men (n=15) and women (n=15) will be recruited for the intramuscular GABA
      injection studies

      Subproject III This study will test the hypothesis that intramuscular injection of GABA with
      glutamate will decrease the intensity of glutamate-evoked muscle pain in healthy human
      subjects. Thirty, pain-free men (n=15) and women (n=15) will be recruited for the
      intramuscular glutamate and GABA injection studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity Rating</measure>
    <time_frame>continuously for 95 minutes</time_frame>
    <description>visual analogue scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Jaw Function Tests</measure>
    <time_frame>every 5 min for 50 minutes</time_frame>
    <description>maximal jaw opening, maximal bite force</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Sensory testing</measure>
    <time_frame>every 10 min for 90 min</time_frame>
    <description>Pressure detection and pain threshold, thermal detection and pain threshold</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>GABA oral solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study will test if oral administration of GABA containing solutions will reduce the pain and sensitivity induced by application of capsaicin to the tongue of healthy human subjects.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intramuscular GABA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study will test the hypothesis that intramuscular injection of GABA alone will not be painful, but will reduce muscle pain sensitivity in healthy human subjects.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pain modulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study will test the hypothesis that intramuscular injection of GABA with glutamate will decrease the intensity of glutamate-evoked muscle pain in healthy human subjects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GABA oral solution</intervention_name>
    <description>Oral mouth wash containing either GABA, lidocaine or distilled water will be used to decrease burning tongue pain produced by capsaicin</description>
    <arm_group_label>GABA oral solution</arm_group_label>
    <other_name>gamma aminobutyric acid</other_name>
    <other_name>lidocaine</other_name>
    <other_name>distilled water</other_name>
    <other_name>capsaicin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intramuscular GABA</intervention_name>
    <description>The effect of intramuscular injection of GABA or lorazepam will be compared with buffered isotonic saline</description>
    <arm_group_label>Intramuscular GABA</arm_group_label>
    <other_name>gamma aminobutyric acid</other_name>
    <other_name>lorazepam</other_name>
    <other_name>buffered isotonic saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pain modulation</intervention_name>
    <description>The effect of GABA alone or in combination with lorazepam on muscle pain produced by intramuscular injection of glutamate will be assessed.</description>
    <arm_group_label>Pain modulation</arm_group_label>
    <other_name>gamma butyric acid</other_name>
    <other_name>glutamate</other_name>
    <other_name>lorazepam</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 20-40 years

          -  Free from ongoing or chronic pain

          -  Adequate conversational English

        Exclusion Criteria:

          -  Pregnancy or intent to become pregnant, breast feeding

          -  Signs or symptoms of any serious systemic diseases

          -  Current malignancies

          -  High blood pressure

          -  Requirement for chronic administration of psychiatric, analgesic or other medications
             that might influence their response to pain

          -  Frequent recreational drug or alcohol use

          -  Previous neurologic, musculoskeletal or mental illnesses

          -  Lack of ability to cooperate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian E Cairns, PhD DrMed</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brian E Cairns, PhD, DrMed</last_name>
    <phone>+45 99407521</phone>
    <email>bec@hst.aau.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalborg University</name>
      <address>
        <city>Aalborg</city>
        <zip>9220</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelun Wang, DDS, PhD</last_name>
      <email>kelun@hst.aau.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>Zhang Y, Wang K, Arendt-Nielsen L, Cairns BE. γ-Aminobutyric acid (GABA) oral rinse reduces capsaicin-induced burning mouth pain sensation: An experimental quantitative sensory testing study in healthy subjects. Eur J Pain. 2018 Feb;22(2):393-401. doi: 10.1002/ejp.1128. Epub 2017 Oct 11.</citation>
    <PMID>29024230</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2016</study_first_submitted>
  <study_first_submitted_qc>October 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2016</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg University</investigator_affiliation>
    <investigator_full_name>Brian E Cairns</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>craniofacial pain</keyword>
  <keyword>masticatory muscle</keyword>
  <keyword>burning mouth syndrome</keyword>
  <keyword>temporomandibular disorders</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Lorazepam</mesh_term>
    <mesh_term>Capsaicin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

